| Literature DB >> 26633428 |
Yin-Di Su1,2, Tung-Ying Wu3, Zhi-Hong Wen4,5, Ching-Chyuan Su6,7, Yu-Hsin Chen8,9, Yu-Chia Chang10,11, Yang-Chang Wu12,13,14,15, Jyh-Horng Sheu16,17, Ping-Jyun Sung18,19,20,21,22.
Abstract
Five new 13,14-epoxybriarane diterpenoids, briarenolides U-Y (1-5), were isolated from the octocoral Briareum sp. The structures of briaranes 1-5 were elucidated by spectroscopic methods. Briarenolides U-Y (1-5) were found to significantly inhibit the expression of the pro-inflammatory inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) protein of the lipopolysaccharide (LPS)-stimulated RAW264.7 macrophage cells.Entities:
Keywords: Briareum; COX-2; anti-inflammatory; briarane; iNOS; octocoral
Mesh:
Substances:
Year: 2015 PMID: 26633428 PMCID: PMC4699233 DOI: 10.3390/md13127060
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Figure 1The structures of briarenolides U–Y (1–5) and briaexcavatolide N (6).
1H (400 MHz, CDCl3) and 13C (100 MHz, CDCl3) NMR data and 1H–1H COSY and HMBC correlations for briarane 1.
| Position | δH ( | δC, Multiple | 1H–1H COSY | HMBC |
|---|---|---|---|---|
| 1 | 41.2, C | |||
| 2 | 4.70 ddd (2.4, 2.0, 2.0) | 77.6, CH | H2-3 | C-1, -4, -10, -15, acetate carbonyl |
| 3 | 3.11 ddd (15.2, 4.8, 2.0); 1.94 m | 40.2, CH2 | H-2, H-4 | C-1, -2, -4, -5 |
| 4 | 4.85 br s | 68.6, CH | H2-3, OH-4 | n. o. a |
| 5 | 147.5, C | |||
| 6 | 5.66 dd (10.4, 1.6) | 116.7, CH | H-7, H2-16 | C-4, -16 |
| 7 | 5.02 d (10.4) | 75.9, CH | H-6 | C-5, -6 |
| 8 | 82.2, C | |||
| 9 | 5.22 d (5.2) | 71.5, CH | H-10 | C-7, -8, -10, -11, acetate carbonyl |
| 10 | 1.81 dd (5.2, 2.8) | 37.3, CH | H-9, H-11 | C-1, -2, -8, -9, -11, -15, -20 |
| 11 | 1.97 m | 42.2, CH | H-10, H-12, H3-20 | n. o. |
| 12 | 3.71 d (4.4) | 70.2, CH | H-11 | C-13, -20 |
| 13 | 3.15 d (3.6) | 59.1, CH | H-14 | C-1 |
| 14 | 2.92 d (3.6) | 63.1, CH | H-13 | C-1, -10, -13, -15 |
| 15 | 1.21 s | 16.9, CH3 | C-1, -2, -10, -14 | |
| 16 | 4.36 br s | 73.2, CH2 | H-6 | C-4, -5, -6, methoxy carbon |
| 17 | 2.36 q (7.2) | 42.5, CH | H3-18 | C-8, -18, -19 |
| 18 | 1.16 d (7.2) | 6.5, CH3 | H-17 | C-8, -17, -19 |
| 19 | 176.1, C | |||
| 20 | 1.07 d (7.2) | 8.7, CH3 | H-11 | C-10, -11, -12 |
| 2-OAc | 172.6, C | |||
| 2.10 s | 21.3, CH3 | Acetate carbonyl | ||
| 9-OAc | 169.0, C | |||
| 2.23 s | 21.9, CH3 | Acetate carbonyl | ||
| 16-OCH3 | 3.46 s | 58.9, CH3 | C-16 | |
| OH-4 | 3.99 d (10.4) | H-4 | n. o. |
a n. o. = not observed.
Figure 2The computer-generated model of 1 using MM2 force field calculations and the calculated distances (Å) between selected protons with key NOESY correlations.
1H (400 MHz, CDCl3) and 13C (100 MHz, CDCl3) NMR data and 1H–1H COSY and HMBC correlations for briarane 2.
| Position | δH ( | δC, Multiple | 1H–1H COSY | HMBC |
|---|---|---|---|---|
| 1 | 40.4, C | |||
| 2 | 4.11 d (10.4) | 75.9, CH | H-3 | C-1, -4, -15 |
| 3 | 5.80 dd (10.4, 10.4) | 135.9, CH | H-2, H-4 | C-5 |
| 4 | 6.31 d (10.4) | 125.5, CH | H-3 | n. o. a |
| 5 | 145.3, C | |||
| 6 | 5.72 d (8.8) | 120.0, CH | H-7 | C-4, -16 |
| 7 | 5.23 d (8.8) | 79.9, CH | H-6 | n. o. |
| 8 | 81.6, C | |||
| 9 | 5.15 d (6.8) | 70.1, CH | H-10 | C-8, -10, -11, -17, acetate carbonyl |
| 10 | 1.96 m | 37.4, CH | H-9, H-11 | C-1, -2, -8, -9, -11, -15, -20 |
| 11 | 2.07 m | 37.8, CH | H-10, H-12, H3-20 | C-10 |
| 12 | 4.73 d (4.4) | 71.8, CH | H-11 | C-13, C-1′ |
| 13 | 3.18 br s | 57.8, CH | C-1 | |
| 14 | 3.18 br s | 62.8, CH | C-1, -15 | |
| 15 | 1.13 s | 15.1, CH3 | C-1, -2, -10, -14 | |
| 16 | 4.29 br s | 63.6, CH2 | n. o. | |
| 17 | 2.28 q (7.2) | 43.4, CH | H3-18 | C-8, -18, -19 |
| 18 | 1.15 d (7.2) | 6.4, CH3 | H-17 | C-8, -17, -19 |
| 19 | 177.2, C | |||
| 20 | 1.04 d (7.2) | 9.5, CH3 | H-11 | C-10, -11, -12 |
| 9-OAc | 170.1, C | |||
| 2.18 s | 21.8, CH3 | Acetate carbonyl | ||
| 12-OC(O)CH2CH2CH3 | ||||
| 1′ 2′ 3′ 4′ | ||||
| 1′ | 173.6, C | |||
| 2′ | 2.35 t (7.2) | 36.2, CH2 | H2-3′ | C-1′, -3′, -4′ |
| 3′ | 1.66 sext (7.2) | 18.3, CH2 | H2-2′, H3-4′ | C-1′, -2′, -4′ |
| 4′ | 0.96 t (7.2) | 13.7, CH3 | H2-3′ | C-2′, -3′ |
a n. o. = not observed.
1H (400 MHz, CDCl3) and 13C (100 MHz, CDCl3) NMR data and 1H–1H COSY and HMBC correlations for briarane 3.
| Position | δH ( | δC, Multiple | 1H–1H COSY | HMBC |
|---|---|---|---|---|
| 1 | 40.4, C | |||
| 2 | 4.21 br s | 71.1, CH | H2-3 | C-1 |
| 3 | 2.46 br d (16.4); 2.10 m | 35.8, CH2 | H-2, H-4 | C-1 |
| 4 | 4.54 d (4.0) | 70.9, CH | H2-3, H2-16 | C-2, -5, -16 |
| 5 | 143.6, C | |||
| 6 | 5.07 br s | 64.1, CH | H-7, H2-16 | n. o. a |
| 7 | 5.05 br s | 77.5, CH | H-6 | n. o. |
| 8 | 83.9, C | |||
| 9 | 5.12 d (5.2) | 73.0, CH | H-10 | C-1, -7, -8, -10, -11, -17, acetate carbonyl |
| 10 | 1.95 m | 37.4, CH | H-9, H-11 | C-8 |
| 11 | 1.94 m | 39.5, CH | H-10, H-12, H3-20 | C-9 |
| 12 | 4.54 d (4.0) | 72.8, CH | H-11, H-13 | C-10, -13, -20, acetate carbonyl |
| 13 | 3.21 d (3.2) | 57.5, CH | H-12, H-14 | n. o. |
| 14 | 3.10 d (3.2) | 63.3, CH | H-13 | C-1 |
| 15 | 1.15 s | 16.7, CH3 | C-1, -2, -10, -14 | |
| 16 | 6.03 br s | 120.6, CH2 | H-4, H-6 | C-4, -5, -6 |
| 17 | 2.38 q (7.2) | 44.0, CH | H3-18 | C-8, -9, -18, -19 |
| 18 | 1.14 d (7.2) | 7.1, CH3 | H-17 | C-8, -17, -19 |
| 19 | 174.7, C | |||
| 20 | 1.06 d (6.8) | 9.5, CH3 | H-11 | C-10, -11, -12 |
| 9-OAc | 169.5, C | |||
| 2.20 s | 21.9, CH3 | Acetate carbonyl | ||
| 12-OAc | 170.2, C | |||
| 2.12 s | 21.0, CH3 | Acetate carbonyl | ||
| OH-8 | 3.37 s | C-7, -8, -9 |
a n. o. = not observed.
1H (400 MHz, CDCl3) and 13C (100 MHz, CDCl3) NMR data and 1H–1H COSY and HMBC correlations for briarane 4.
| Position | δH ( | δC, Multiple | 1H–1H COSY | HMBC |
|---|---|---|---|---|
| 1 | 40.4, C | |||
| 2 | 4.20 br s | 71.4, CH | H2-3 | n. o. a |
| 3 | 2.45 br d (16.4); 2.13 m | 37.4, CH2 | H-2, H-4 | n. o. |
| 4 | 4.54 br d (5.2) | 70.5, CH | H2-3, H2-16 | n. o. |
| 5 | 143.8, C | |||
| 6 | 5.06 br s | 64.1, CH | H2-16 | C-7 |
| 7 | 5.05 br s | 77.5, CH | n. o. | |
| 8 | 83.8, C | |||
| 9 | 5.13 d (5.2) | 73.2, CH | H-10 | C-7, -8, -11, -17, acetate carbonyl |
| 10 | 1.98 m | 37.6, CH | H-9 | n. o. |
| 11 | 1.96 m | 39.7, CH | H-12, H3-20 | n. o. |
| 12 | 4.58 d (4.4) | 72.5, CH | H-11 | C-1′ |
| 13 | 3.21 d (3.6) | 57.3, CH | H-14 | n. o. |
| 14 | 3.09 d (3.6) | 63.2, CH | H-13 | C-13 |
| 15 | 1.16 s | 16.6, CH3 | C-1, -2, -10, -14 | |
| 16 | 6.03 d (2.0); 6.02 br s | 120.6, CH2 | H-4, H-6 | C-4, -5, -6 |
| 17 | 2.39 q (7.2) | 44.1, CH | H3-18 | C-8, -18, -19 |
| 18 | 1.14 d (7.2) | 7.1, CH3 | H-17 | C-8, -17, -19 |
| 19 | 174.4, C | |||
| 20 | 1.06 d (7.2) | 9.5, CH3 | H-11 | C-10, -11, -12 |
| 9-OAc | 169.5, C | |||
| 2.20 s | 21.9, CH3 | Acetate carbonyl | ||
| 12-OC(O)CH2CH2CH3 | ||||
| 1′ 2′ 3′ 4′ | ||||
| 1′ | 172.7, C | |||
| 2′ | 2.35 t (7.2) | 36.2, CH2 | H2-3′ | C-1′, -3′, -4′ |
| 3′ | 1.69 sext (7.2) | 18.4, CH2 | H2-2′, H3-4′ | C-1′, -2′, -4′ |
| 4′ | 0.98 t (7.2) | 13.7, CH3 | H2-3′ | C-2′, -3′ |
| OH-8 | 3.35 s | C-8, -9 |
a n. o. = not observed.
1H (400 MHz, CDCl3) and 13C (100 MHz, CDCl3) NMR data and 1H–1H COSY and HMBC correlations for briarane 5.
| Position | δH ( | δC, Multiple | 1H–1H COSY | HMBC |
|---|---|---|---|---|
| 1 | 41.4, C | |||
| 2 | 5.08 d (9.2) | 71.9, CH | H-3 | C-1, -3, -4, -14, -15 |
| 3 | 5.80 dd (12.0, 9.2) | 134.7, CH | H-2, H-4 | n. o. a |
| 4 | 6.07 d (12.0) | 126.0, CH | H-3, H2-16 | C-2, -3, -16 |
| 5 | 138.1, C | |||
| 6 | 5.73 d (9.6) | 75.5, CH | H-7, H2-16 | C-4, -5, -7, -16, acetate carbonyl |
| 7 | 4.67 d (9.6) | 81.6, CH | H-6 | C-6 |
| 8 | 80.4, C | |||
| 9 | 5.26 d (7.6) | 69.9, CH | H-10 | C-7, -8, -10, -11, -17, acetate carbonyl |
| 10 | 2.15 m | 36.5, CH | H-9, H-11 | C-1, -2, -8, -9, -11, -15, -20 |
| 11 | 2.04 m | 37.3, CH | H-10, H-12, H3-20 | C-12 |
| 12 | 4.63 d (4.4) | 72.7, CH | H-11 | C-10, -13, -14, -20, acetate carbonyl |
| 13 | 3.25 d (3.6) | 57.8, CH | H-13 | n. o. |
| 14 | 3.17 d (3.6) | 62.6, CH | H-14 | C-1, -10, -15 |
| 15 | 1.07 s | 14.8, CH3 | C-1, -2, -10, -14 | |
| 16 | 5.63 s; 5.50 s | 122.2, CH2 | H-4, H-6 | C-4, -5, -6 |
| 17 | 2.46 q (7.2) | 45.0, CH | H3-18 | C-8, -9, -18, -19 |
| 18 | 1.14 d (7.2) | 6.2, CH3 | H-17 | C-8, -17, -19 |
| 19 | 175.1, C | |||
| 20 | 1.04 d (7.2) | 9.3, CH3 | H-11 | C-10, -11, -12 |
| 6-OAc | 170.1, C | |||
| 2.09 s | 21.3, CH3 | Acetate carbonyl | ||
| 9-OAc | 170.4, C | |||
| 2.18 s | 21.9, CH3 | Acetate carbonyl | ||
| 12-OAc | 170.6, C | |||
| 2.13 s | 21.1, CH3 | Acetate carbonyl |
a n. o. = not observed.
Figure 3The computer-generated model of 5 using MM2 force field calculations and the calculated distances (Å) between selected protons with key NOESY correlations.
Figure 4Effects of compounds briarenolides U–Y (1–5) on pro-inflammatory iNOS and COX-2 protein expression in the LPS-stimulated murine macrophage cell line RAW264.7. (A) The relative density of iNOS immunoblot; (B) the relative density of COX-2 immunoblot. The relative intensity of the LPS-stimulated group was taken to be 100%. Band intensities were quantified by densitometry and are indicated as the percent change relative to that of the LPS-stimulated group. Briarenolides U–Z (1–5) and dexamethasone (Dex) significantly inhibited LPS-induced iNOS and COX-2 protein expression in macrophages. The experiments were repeated three times (* p < 0.05, significantly different from the LPS-stimulated group).
| iNOS | Cox-2 | |
|---|---|---|
| Expression (% of LPS) | Expression (% of LPS) | |
| Control | 7.76 ± 1.99 | 2.2 ± 1.0 |
| LPS | 100 ± 0 | 100 ± 0 |
| U ( | 41.9 ± 15.0 | 26.1 ± 7.7 |
| V ( | 47.3 ± 16.5 | 35.6 ± 8.3 |
| W ( | 50.1 ± 9.3 | 58.1 ± 8.1 |
| X ( | 66.2 ± 6.7 | 67.2 ± 9.9 |
| Y ( | 54.3 ± 9.6 | 55.4 ± 16.2 |
| Dexamethasone a | 26.7 ± 14.1 | 10.1 ± 6.8 |
a Dexamethasone (Dex) was used as a positive control.